Aldeyra Therapeutics, Inc. (ALDX): Total Assets
$72.06M
As of 2025-12-31
$47.54M
As of 2026-06-30
-26.5%
3-year compound annual growth
-2.9%
5-year compound annual growth
+9.8%
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $72.06M | -31.1% | 2026-02-27, Balance as of period end |
| 2024-12-31 | $104.61M | -29.5% | 2026-02-27, Balance as of period end |
| 2023-12-31 | $148.33M | -18.2% | 2025-02-28, Balance as of period end |
| 2022-12-31 | $181.29M | -22.2% | 2024-03-07, Balance as of period end |
| 2021-12-31 | $233.14M | +179.7% | 2023-03-09, Balance as of period end |
| 2020-12-31 | $83.35M | +10.4% | 2022-03-17, Balance as of period end |
| 2019-12-31 | $75.52M | -20.6% | 2021-03-11, Balance as of period end |
| 2018-12-31 | $95.09M | +115.3% | 2020-03-12, Balance as of period end |
| 2017-12-31 | $44.17M | +75.4% | 2019-03-08, Balance as of period end |
| 2016-12-31 | $25.19M | -10.7% | 2018-03-29, Balance as of period end |
| 2015-12-31 | $28.20M | +221.0% | 2017-03-30, Balance as of period end |
| 2014-12-31 | $8.79M | +134.7% | 2016-03-30, Balance as of period end |
| 2013-12-31 | $3.74M | n/a | 2015-03-23, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Aldeyra Therapeutics, Inc. (ALDX) | 2025-12-31 | $72.06M | -31.1% |
| Corvus Pharmaceuticals, Inc. (CRVS) | 2025-12-31 | $71.12M | +3.2% |
| Inovio Pharmaceuticals, Inc. (INO) | 2025-12-31 | $74.31M | -34.4% |
| Werewolf Therapeutics, Inc. (HOWL) | 2025-12-31 | $69.40M | -45.3% |
| Spero Therapeutics, Inc. (SPRO) | 2025-12-31 | $68.92M | -37.7% |
| Context Therapeutics Inc. (CNTX) | 2025-12-31 | $68.49M | -30.2% |
| Cumberland Pharmaceuticals Inc (CPIX) | 2025-12-31 | $76.82M | +1.6% |
| Grace Therapeutics, Inc. (GRCE) | 2026-03-31 | $66.65M | -7.4% |
| Adagene Inc. (ADAG) | 2025-12-31 | $78.26M | -12.3% |
Compare ALDX, CRVS, INO, HOWL side by side · Screen every company in Pharmaceutical Preparations ↗